Maternal Key Nutritional Factors and Offspring's Atopic Dermatitis (MKNFOAD) (MKNFOAD)

March 16, 2023 updated by: Weili Yan, Children's Hospital of Fudan University

Maternal Key Nutritional Factors and Offspring's Atopic Dermatitis

The study is a prospective birth cohort study and the purpose is to describe the status of maternal key nutrients(eg. folate and vitamin D) supplementation among pregnancies at early gestation in Shanghai, to find out the association between the level of serum key nutrients and atopic dermatitis (AD) in offsprings during 6 months.

Study Overview

Detailed Description

This study based on Shanghai pregnancy population is a prospective birth cohort. The investigators obtain the data of participants' folic acid and vitamin D supplement intake through the questionnaire at 12-14 gestational weeks. And the investigators collect participants' blood samples during gestation to directly detect the biological exposure levels of folate and vitamin D. In the follow-up, skin barrier function is evaluated at time of infant 24-48 hours, 42 days and 6 months. During 6 months from birth, the incidence of AD is investigated on offsprings. This cohort study is aimed to (1) clarify the association between prenatal key nutrients with offspring AD; (2) assess the role of maternal key nutrients in the skin barrier of offsprings. It will be a good evidence for the AD prevention and a meaningful protocol to reduce the incidence of AD by its unique design.Univariate and multivariate association analyses will be performed to identify risk factors to AD by using multivariate logistic regression model.

Study Type

Observational

Enrollment (Actual)

487

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Shanghai, China, 201102
        • Children Hospital of Fudan University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Pregancies at early gestation and offspring from Minhang Maternal and Children Health Care Hospital in Shanghai from June 2016

Description

Inclusion Criteria:

  • Mother plans to proceed prenatal care and delivery in Minhang Maternal and Children Health Care Hospital
  • Offspring plans to stay in Shanghai until 6 months and proceed follow-up in Children's Hospital of Fudan University

Exclusion Criteria:

  • none

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
infants from birth cohort with AD
maternal biological folate level and maternal biological vitamin D level and offspring's incidence of suffering from atopic dermatitis
supplementation status and serum level
supplementation status and serum level
infants from birth cohort without AD
maternal biological folate level and maternal biological vitamin D level and offspring's incidence of not suffering from atopic dermatitis
supplementation status and serum level
supplementation status and serum level

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Infant atopic dermatitis
Time Frame: incident of AD during 6 months after birth, diagnosis confirmed based on disease history till 12 months
Disease diagnosis according to the criteria of Williams
incident of AD during 6 months after birth, diagnosis confirmed based on disease history till 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maternal RBC folate level
Time Frame: 12-14 gestational weeks
Whole blood sample collected will be used for evaluation
12-14 gestational weeks
Maternal serum vitamin D level
Time Frame: 12-14 gestational weeks
Serum sample collected at different trimesters will be used for evaluation
12-14 gestational weeks
Maternal serum vitamin D level
Time Frame: 22-26 gestational weeks
Serum sample collected at different trimesters will be used for evaluation
22-26 gestational weeks
Maternal serum vitamin D level
Time Frame: 34-36 gestational weeks
Serum sample collected at different trimesters will be used for evaluation
34-36 gestational weeks
Maternal serum folate level
Time Frame: 12-14 gestational weeks
Serum sample collected at different trimesters will be used for evaluation
12-14 gestational weeks
Maternal serum folate level
Time Frame: 22-26 gestational weeks
Serum sample collected at different trimesters will be used for evaluation
22-26 gestational weeks
Maternal serum folate level
Time Frame: 34-36 gestational weeks
Serum sample collected at different trimesters will be used for evaluation
34-36 gestational weeks
Maternal folic acid supplement intake
Time Frame: 12-14 gestational weeks
Questionnaire survey will be used to obtain the data of maternal supplement intake
12-14 gestational weeks
Maternal vitamin D supplement intake
Time Frame: 12-14 gestational weeks
Questionnaire survey will be used to obtain the data of maternal supplement intake
12-14 gestational weeks
Infant skin barrier function (Transepidermal Water Loss, TEWL)
Time Frame: infant 24-48 hours
TEWL will be evaluated by the device of Multi Probe Adapter 4.
infant 24-48 hours
Infant skin barrier function (Transepidermal Water Loss, TEWL)
Time Frame: infant 42 days old
TEWL will be evaluated by the device of Multi Probe Adapter 4.
infant 42 days old
Infant skin barrier function (Transepidermal Water Loss, TEWL)
Time Frame: infant 6 months old
TEWL will be evaluated by the device of Multi Probe Adapter 4.
infant 6 months old
Infant atopic dermatitis incidence by 1year old
Time Frame: from birth , to 12months old
Disease diagnosis according to the criteria of Williams
from birth , to 12months old
Infant skin barrier function (Stratum corneum hydration, SCH)
Time Frame: infant 24-48 hours
SCH will be evaluated by the device of Multi Probe Adapter 4.
infant 24-48 hours
Infant skin barrier function (Stratum corneum hydration, SCH)
Time Frame: infant 42 days old
SCH will be evaluated by the device of Multi Probe Adapter 4.
infant 42 days old
Infant skin barrier function (Stratum corneum hydration, SCH)
Time Frame: infant 6 months old
SCH will be evaluated by the device of Multi Probe Adapter 4.
infant 6 months old
Infant skin barrier function (skin surface pH)
Time Frame: infant 24-48 hours
Skin pH will be evaluated by the device of Multi Probe Adapter 4.
infant 24-48 hours
Infant skin barrier function (skin surface pH)
Time Frame: infant 42 days old
Skin pH will be evaluated by the device of Multi Probe Adapter 4.
infant 42 days old
Infant skin barrier function (skin surface pH)
Time Frame: infant 6 months old
Skin pH will be evaluated by the device of Multi Probe Adapter 4.
infant 6 months old
Infant skin barrier function (sebum content)
Time Frame: infant 24-48 hours
Sebum content will be evaluated by the device of Multi Probe Adapter 4.
infant 24-48 hours
Infant skin barrier function (sebum content)
Time Frame: infant 42 days old
Sebum content will be evaluated by the device of Multi Probe Adapter 4.
infant 42 days old
Infant skin barrier function (sebum content)
Time Frame: infant 6 months old
Sebum content will be evaluated by the device of Multi Probe Adapter 4.
infant 6 months old
Maternal serum Vitamin E level
Time Frame: 12-14 gestational weeks
Serum sample collected at different trimesters will be used for evaluation
12-14 gestational weeks
Maternal serum Vitamin A level
Time Frame: 12-14 gestational weeks
Serum sample collected at different trimesters will be used for evaluation
12-14 gestational weeks
Child atopic dermatitis from 1 year old to 2 years old
Time Frame: from 1 year old to 2 years old
Disease diagnosis according to the criteria of Williams
from 1 year old to 2 years old
Child atopic dermatitis from 2 years old to 5 years old
Time Frame: from 2 years old to 5 years old
Disease diagnosis according to the criteria of Williams
from 2 years old to 5 years old

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Guoying Huang, MD,PhD, Children's Hospital of Fudan University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2016

Primary Completion (Actual)

October 31, 2017

Study Completion (Actual)

April 30, 2018

Study Registration Dates

First Submitted

August 31, 2016

First Submitted That Met QC Criteria

August 31, 2016

First Posted (Estimate)

September 5, 2016

Study Record Updates

Last Update Posted (Actual)

March 20, 2023

Last Update Submitted That Met QC Criteria

March 16, 2023

Last Verified

March 1, 2023

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Atopic Dermatitis

Clinical Trials on maternal biological folate level

3
Subscribe